3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
3
Genitourinary
3
Other solid neoplasm
2
Myeloid
2
Sarcoma
1
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Cisplatin
263
Radiotherapy
166
Cetuximab
159
Docetaxel
105
Fluorouracil
104
pembrolizumab
94
Radiotherapy, Intensity-Modulated
83
Carboplatin
80
Paclitaxel
73
Nivolumab
59
Erlotinib Hydrochloride
35
Surveys and Questionnaires
32
Gemcitabine
32
durvalumab
30
Radiation
29
Drug Therapy
25
Immunohistochemistry
21
Gefitinib
21
Capecitabine
21
tremelimumab
18
Bevacizumab
18
Surgical Procedures, Operative
17
Sorafenib
17
Magnetic Resonance Spectroscopy
17
Ipilimumab
17
Pemetrexed
16
lenvatinib
15
atezolizumab
15
Radiosurgery
15
Gene Expression Profiling
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Molecular Diagnostic Techniques
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled